Table 2   Clinical baseline of HCC patients

Age (years) (mean ± SD)

49.8 ± 9.3

51.8 ± 11.6

0.354

Gender (Male/Female)

40/7

39/8

0.778

HBsAg (positive/negative)

40/7

39/8

0.778

Cirrhosis (positive/negative)

26/21

19/28

0.148

Child–Pugh classification(A/B)

46/1

45/2

0.554

AFP (ng/mL)

0.626

 ≥ 400

35

37

 < 400

12

10

Biggest tumor diameter (cm) (mean ± SD)

6.8 ± 4.6

6.0 ± 4.8

0.363

Blood transfusion (positive/negative)

8/39

6/41

0.562

Microvascular invasion (positive/negative)

18/29

17/30

0.831

Portal vein invasion (positive/negative)

4/43

2/45

0.399

Tumor capsule (positive/negative)

9/38

10/37

0.797

BCLC stage

0.779

 A

14

17

 B

29

27

 C

4

3